Showing results (591-600 of 777) with videos related to

Sort By:
Pageof 78
The Prostate|July 17, 2015
PTEN loss and ERG protein expression are infrequent in prostatic ductal adenocarcinomas and concurrent acinar carcinomasCarlos L Morais, Mehsati Herawi, Antoun Toubaji, et al.
Urology|June 28, 2011
Immunohistochemical analysis of SMARCB1/INI-1 expression in collecting duct carcinomaHillary Elwood, Alcides Chaux, Luciana Schultz, et al.
The Journal of Urology|October 12, 2005
Obesity and capsular incision at the time of open retropubic radical prostatectomyStephen J Freedland, Kelly A Grubb, Sindy K Yiu, et al.
Urology|January 11, 2011
ProPSA and diagnostic biopsy tissue DNA content combination improves accuracy to predict need for prostate cancer treatment among men enrolled in an active surveillance programSumit Isharwal, Danil V Makarov, Lori J Sokoll, et al.
Cancer|December 12, 2003
Quantitative alterations in nuclear structure predict prostate carcinoma distant metastasis and death in men with biochemical recurrence after radical prostatectomyMasood A Khan, Patrick C Walsh, M Craig Miller, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 26, 2009
Pro-prostate-specific antigen measurements in serum and tissue are associated with treatment necessity among men enrolled in expectant management for prostate cancerDanil V Makarov, Sumit Isharwal, Lori J Sokoll, et al.
The Journal of Urology|December 17, 2009
Accuracy of PCA3 measurement in predicting short-term biopsy progression in an active surveillance programJeffrey J Tosoian, Stacy Loeb, Anna Kettermann, et al.
BJU International|July 2, 2016
Prediction of pathological stage based on clinical stage, serum prostate-specific antigen, and biopsy Gleason score: Partin Tables in the contemporary eraJeffrey J Tosoian, Meera Chappidi, Zhaoyong Feng, et al.
Urology|October 18, 2002
Complexed prostate-specific antigen as a staging tool for prostate cancer: a prospective study in 420 menLori J Sokoll, Leslie A Mangold, Alan W Partin, et al.
BJU International|February 11, 2020
Utility of multiparametric magnetic resonance imaging in the risk stratification of men with Grade Group 1 prostate cancer on active surveillanceMufaddal K Mamawala, Alexa R Meyer, Patricia K Landis, et al.
Pageof 78